Professor Martini, a Director at Rainbow Medical Engineering, will work within the College’s Institute of Pharmaceutical Science to ensure new discoveries and inventions across King’s Health Partners are transferred to clinical and pharmaceutical development.
Professor Martini said he was “honoured” to join the “first-class institution” and that the role demonstrates the “King’s visionary leadership and ambition”.
Prior to joining Rainbow, the professor was a senior director of preclinical and pharmaceutical development for Emerging Markets and Asia Pacific at GSK. He is also a Fellow of the Royal Pharmaceutical Society of Great Britain.
King’s Health Partners is one of five academic health sciences centres across the UK that provide health care to patients and undertake research. It combines the King’s College London University and the three NHS Foundation Trusts: Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley.